fda approval of tirzepatide for Zepbound (tirzepatide) injection, the first and only obesity treatment its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Eli Lilly Gets FDA Approval

GLP-1 Receptor Agonist Discontinuation Among Patients With Obesity and/or Type 2 Diabetes

How does cagrilintide affect insulin secretion compared to survodutide

Some customers report that Brello providers are responsive about titration changes

3.7 Grape seed extract and vitamin C modulated the immune cell infiltration in tumors The immunoreactivity of various lymphocyte subsets infiltrating the tumors showed membranous, cytoplasmic, and peritumor staining for FOXP3, CD4, and CD8 surface markers

But because there arent published human clinical trials on KPV, we simply dont yet know how this translates to humans, what dosing ranges are best, or whether it's safe over the long term